InfuSystem Holdings (INFU) Return on Capital Employed (2011 - 2026)
InfuSystem Holdings (INFU) posted Return on Capital Employed of 15.63% for Q1 2026, up 4.31% on a QoQ basis from 14.99% in Q4 2025, and up 614.0% year-over-year from 2.19% in Q1 2025.
InfuSystem Holdings (INFU) Return on Capital Employed (2011 - 2026) Analysis & Trends
InfuSystem Holdings' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 15.63% for Q1 2026.
- Quarterly Return on Capital Employed rose 614.0% year-over-year to 15.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.63% (up 614.0% YoY) and the FY2025 annual result came in at 14.55%, up 650.0% from the prior year.
- Return on Capital Employed was 15.63% for Q1 2026 at InfuSystem Holdings, up from 14.99% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 15.63% in Q1 2026 and bottomed at 1.11% in Q2 2022.
- A 5-year average of 6.47% and a median of 4.39% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 1015 bps — and 2025, when it surged 749 bps.
- InfuSystem Holdings' Return on Capital Employed stood at 1.95% in 2022, then soared by 141 bps to 4.71% in 2023, then jumped by 69 bps to 7.94% in 2024, then surged by 89 bps to 14.99% in 2025, then increased by 4 bps to 15.63% in 2026.
- Business Quant data shows INFU's Return on Capital Employed at 15.63% in Q1 2026, 14.99% in Q4 2025, and 13.34% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 15.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.63% |
| Dec 31, 2025 | 14.99% |
| Sep 30, 2025 | 13.34% |
| Jun 30, 2025 | 11.85% |
| Mar 31, 2025 | 9.50% |
| Dec 31, 2024 | 7.94% |
| Sep 30, 2024 | 6.14% |
| Jun 30, 2024 | 4.36% |
| Mar 31, 2024 | 3.87% |
| Dec 31, 2023 | 4.71% |
| Sep 30, 2023 | 4.39% |
| Jun 30, 2023 | 3.47% |
| Mar 31, 2023 | 2.38% |
| Dec 31, 2022 | 1.95% |
| Sep 30, 2022 | 2.58% |
| Jun 30, 2022 | 1.11% |
| Mar 31, 2022 | 1.69% |
| Dec 31, 2021 | 3.39% |
| Sep 30, 2021 | 2.78% |
| Jun 30, 2021 | 7.56% |